Gastrointestinal Surgery (all articles)
Pragmatic randomized trial found similar rates of surgical site infectious with 2% alcoholic chlorhexidine skin preparation compared with povidone–iodine, or with triclosan-coated sutures compared with non-coated sutures.
26 Oct, 2021 | 01:52h | UTCCommentaries:
Prevention of surgical site infection in low-resource settings – The Lancet
Commentary on Twitter
2% alcoholic chlorhexidine skin preparation and triclosan-coated sutures – no benefit in preventing surgical site infection in clean-contaminated or contaminated or dirty surgical woundshttps://t.co/QVkdYYmDvP pic.twitter.com/8hAO5lqFTV
— K Pavithran (@drkpavithran) October 25, 2021
RCT: Laparoscopic vs. open distal gastrectomy for locally advanced gastric cancer.
26 Oct, 2021 | 01:40h | UTCLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary on Twitter
It is not clear whether laparoscopic (LDG) and open distal gastrectomy (ODG) produce similar long-term outcomes in advanced #gastriccancer. CLASS-01 trial firstly shows LDG results in similar 5-year OS compared to ODG in advanced gastric cancer https://t.co/uUBcLFeqsY
— JAMA Surgery (@JAMASurgery) October 20, 2021
M-A: Strategies for antibiotic administration for bowel preparation among patients undergoing elective colorectal surgery – “the addition of oral antibiotics to intravenous antibiotics was associated with a reduction in the incidence of incisional surgical site infection by more than 50%”.
26 Oct, 2021 | 01:42h | UTCStrategies for Antibiotic Administration for Bowel Preparation Among Patients Undergoing Elective Colorectal Surgery: A Network Meta-analysis – JAMA Surgery (free for a limited period)
Commentaries:
Bowel Preparation for Colorectal Surgery: Have All Questions Been Answered? – JAMA Surgery (free for a limited period)
Oral Abx Cut Surgical Site Infections in Colorectal Surgeries — Network meta-analysis finds over 50% SSI reduction with addition of oral to IV antibiotics – MedPage Today (free registration required)
Commentary on Twitter
Network meta-analysis demonstrates that use of oral antibiotics in addition to IV antibiotics greatly reduce the incidence of incisional SSI in elective colorectal surgery https://t.co/pUoWzsmm56
— JAMA Surgery (@JAMASurgery) October 22, 2021
Guidelines for the surgical management of ulcerative colitis.
17 Oct, 2021 | 21:21h | UTC
Commentary on Twitter
@ASCRS_1 Clinical Practice Guidelines – Surgical Management of #UlcerativeColiltis – what do you think? https://t.co/om9IBPoO5S@HolubarStefan @AmyLightnerMD @VitaliyPoylin @JonVogel7 @BradleyDavisMD @UmaMahadevanIBD @DrSamirAShah1 @SunandaKaneMD @ScottRSteeleMD @ianmpaquette pic.twitter.com/D2eywXrATE
— DCRjournal (@DCRjournal) July 9, 2021
RCT: Among patients with metastatic colorectal cancer, those randomized to systemic treatment alone had lower sixty-day mortality compared to those randomized to primary tumor resection followed by systemic treatment.
12 Oct, 2021 | 00:01h | UTCSixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Editorial: Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials – JAMA Surgery (free for a limited period)
Commentary: Systemic Therapy Alone Bests Surgical Tx for Metastatic CRC – BreakingMed
Commentary on Twitter
Early mortality in patients with colorectal cancer and unresectable metastases randomized to primary tumor resection followed by systemic treatment is considerably higher than early mortality in patients randomized to systemic treatment only https://t.co/SyfYjmDU7i @DaveKruijssen
— JAMA Surgery (@JAMASurgery) October 11, 2021
ACG Clinical Guidelines: Management of Benign Anorectal Disorders
10 Oct, 2021 | 21:29h | UTC
Commentary on Twitter
🆕 2021 ACG Guidelines for Benign Anorectal Disorders 🍑🍑🍑
👉defecation disorders
👉proctalgia syndromes
👉hemorrhoids
👉anal fissures
👉fecal incontinence #GITwitter🔗 https://t.co/TeqTWjQkg1 pic.twitter.com/gEfkBsH7kn
— Carl Kay, MD (@CarlKayMD) October 8, 2021
RCT: Immediate drainage did not improve outcomes compared to postponed intervention in patients with infected necrotizing pancreatitis.
7 Oct, 2021 | 10:35h | UTC
Large observational study suggests sleeve gastrectomy may be safer compared to gastric bypass in patients with severe obesity.
7 Oct, 2021 | 10:26h | UTCComparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity – JAMA Surgery (free for a limited period)
Commentaries:
Compared to What?—Novel Methods to Approach Randomization for Long-term Bariatric Surgery Outcomes – JAMA Surgery (free for a limited period)
Of two common weight loss surgeries, one is safer but less effective – Michigan Medicine
Related:
Cohort study: comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass
Cohort study: interventions and operations 5 years after bariatric surgery
Randomized trial: gastric bypass superior to sleeve gastrectomy for remission of type 2 diabetes
Research: laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass
Commentary on Twitter
Study suggests that the safety benefits of sleeve gastrectomy persist up to 5 years after surgery; this information may help patients and surgeons make informed treatment decisions https://t.co/JuRQGh3byz
— JAMA Surgery (@JAMASurgery) October 6, 2021
RCT: Transanal drainage tube use does not prevent anastomotic leakage after laparoscopic low anterior resection in patients with rectal cancer.
7 Oct, 2021 | 10:27h | UTCTransanal Drainage Tube Use for Preventing Anastomotic Leakage After Laparoscopic Low Anterior Resection in Patients With Rectal Cancer: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Invited commentary: Transanal Drainage Tubes—Prevention of Leaks or Unnecessary Sump? – JAMA Surgery (free for a limited period)
European Hernia Society guidelines on management of rectus diastasis.
6 Oct, 2021 | 10:02h | UTCEuropean Hernia Society guidelines on management of rectus diastasis – British Journal of Surgery
Commentary on Twitter
🚨🚨🚨🆕@eurohernias Clinical Practice Guideline on the management of rectus #diastasis🚨🚨🚨
Read it for 🆓 here: https://t.co/fxAqcZXrq5#OpenAccess🔓 #SoMe4Surgery #ItsNotJustAHernia #SoMe4Hernia pic.twitter.com/xJS3h0INCd
— BJS (@BJSurgery) October 1, 2021
Intra-abdominal hypertension and abdominal compartment syndrome in critically ill patients: A narrative review of past, present, and future steps.
5 Oct, 2021 | 08:52h | UTC
A new surgical robot is smaller, nimbler, and cheaper, its maker claims. But will it be better for patients?
3 Oct, 2021 | 22:26h | UTC
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections.
1 Oct, 2021 | 10:24h | UTCRelated:
RCT: Doxycycline better than Azithromycin for the treatment of rectal Chlamydia in men who have sex with men.
1 Oct, 2021 | 10:09h | UTC
RCT: Neurolytic splanchnic nerve block and pain relief, survival, and quality of life in unresectable pancreatic cancer.
30 Sep, 2021 | 10:16h | UTC
Commentary on Twitter
Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial https://t.co/xa9sPAdQu1 pic.twitter.com/gi74fdDSfl
— Anesthesiology (@_Anesthesiology) August 30, 2021
Gastrointestinal stromal tumors: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
30 Sep, 2021 | 10:11h | UTC
Roux‐en‐Y versus Billroth‐I reconstruction after distal gastrectomy for gastric cancer.
19 Sep, 2021 | 23:24h | UTC
WSES-AAST Guidelines: Anorectal Emergencies.
17 Sep, 2021 | 10:06h | UTCAnorectal emergencies: WSES-AAST guidelines – World Journal of Emergency Surgery
Review: Is there an optimal antiplatelet strategy after gastrointestinal bleeding in patients with coronary artery disease?
16 Sep, 2021 | 09:57h | UTC
State of the Art Review: Screening and prevention of colorectal cancer.
16 Sep, 2021 | 10:01h | UTCScreening and prevention of colorectal cancer – The BMJ (free for a limited period)
Related:
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer.
16 Sep, 2021 | 09:52h | UTC
Commentary on Twitter
Clinical Practice Guidelines – Surveillance and Survivorship shown in #DCRJournal visual abstract by @ianmpaquette @JMigaly @ASCRS_1. What do you think? https://t.co/e3kADOerpq@JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD pic.twitter.com/wOhu0Mby60
— DCRjournal (@DCRjournal) May 9, 2021
Consensus Guideline: Liver transplantation for non-resectable colorectal liver metastases.
16 Sep, 2021 | 09:50h | UTCLiver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines – The Lancet Gastroenterology & Hepatology (free registration required)
Commentary on Twitter
New online – Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelineshttps://t.co/oZL4X4h7VS@IHPBA @gbonneysurg @eahpba @_ilts_#livertwitter #APHPBA_2021 pic.twitter.com/g6rrVclV5h
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2021
Five hundred patients with gut malrotation: thirty years of experience with the introduction of a new surgical procedure.
16 Sep, 2021 | 09:48h | UTC
RCT: Effect of Camrelizumab vs. placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma.
15 Sep, 2021 | 08:51h | UTCEffect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma—Renewed Enthusiasm and a Lingering Challenge – JAMA Oncology (free for a limited period)
Commentary on Twitter
Among patients with advanced or metastatic esophageal squamous cell carcinoma, the addition of camrelizumab to chemotherapy, compared with placebo and chemotherapy, significantly improved overall survival and progression-free survival https://t.co/DAlhmtgvv1
— JAMA (@JAMA_current) September 14, 2021
Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass.
12 Sep, 2021 | 21:37h | UTCOriginal study: Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy – JAMA Network Open
Commentary on Twitter
Cohort study found that 4-year healthcare expenditures associated with Roux-en-Y gastric bypass (RYGB) surgery and sleeve gastrectomy (SG) did not differ in Ontario, Canada. https://t.co/pegVdcwgJG
— JAMA Network Open (@JAMANetworkOpen) September 9, 2021


